Patent · US Active

SNS-595 and methods of using the same

US8822493B2 · kind B2 · utility

3Cited by
12References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2013
Grant dateSep 2, 2014
Priority date
Expiry dateMar 11, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02E70/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to SNS-595 and methods of treating cancer using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.